← Eichor
Condition: Ipf Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ipf

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Korean Idiopathic Pulmonary Fibrosis Registry
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT04160715A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants
Phase 1 · 2 location(s) · Endeavor Biomedicines, Inc. · NCT07454291Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Phase 2 · 1 location(s) · Peter Caravan · NCT07572383FAPI PET for Lung Fibrosis
EARLY_Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05365802Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NA · 2 location(s) · Assiut University · NCT05842681Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)
NA · 2 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07457463Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Phase 2 · 2 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03803787Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06036719A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idi
Phase 2 · 12 location(s) · Shanghai Synvida Biotechnology Co.,Ltd. · NCT07121413Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
NA · 1 location(s) · Katerina M. Antoniou · NCT07466420H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696SB17170 Phase 2 Trial in IPF Patients
Phase 2 · 5 location(s) · SPARK Biopharma · NCT06747923A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT05895409Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Phase 3 · 165 location(s) · United Therapeutics · NCT05943535Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonar
Phase 2 · 6 location(s) · AbbVie · NCT07230288Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Phase 2 · 1 location(s) · Erasme University Hospital · NCT06189820Database and Biobank of Patients With Hypersensitivity Pneumonitis
Phase N/A · 1 location(s) · Nils Hoyer · NCT05549635Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07541638Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Phase N/A · 44 location(s) · Duke University · NCT01915511HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Modena and Reggio Emilia · NCT07373288Turkish Validity and Reliability of SGRQ-I
Phase N/A · 1 location(s) · Saglik Bilimleri Universitesi · NCT05147597Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Phase 2 · 12 location(s) · InSilico Medicine Hong Kong Limited · NCT05975983Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT03535545The Genetics of Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT03478553Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
Phase N/A · 1 location(s) · National Hospital Organization Minami Kyoto Hospital · NCT05193136Effects of Pulmonary Diseases and Their Treatment on Cardiac Function
Phase N/A · 1 location(s) · Ayham Daher · NCT05042219Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Dragonboat Biopharmaceutical Company Limited · NCT07447102Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT06853145P4O2 ILD Extension
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06644144A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
EARLY_Phase 1 · 1 location(s) · Shanghai Synvida Biotechnology Co.,Ltd. · NCT06267183
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.